Companies: 10,795·Total market cap: $144.5T
AstraZeneca PLC

AstraZeneca PLC

AZNNYSEHealthcare● Active
$185.95
+$4.15(+2.28%)
Market Cap$288.4B
P/E Ratio
52W High$212.71
52W Low$137.22

AstraZeneca PLC (AZN) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

AZN · net income · updated Jun 8, 2026

Core profitability metrics

Net income was $10.26B for FY2025 (fiscal year ending 2025-12-31), up 45.8% year-over-year. Net profit margin was 17.5%. Based on available data, AstraZeneca PLC has been profitable since at least 2011.

FY2025 Net Income$10.26B▲ +45.8% YoY
Trailing 12M (TTM)$10.39Btrailing 4 quarters sum
Net Profit Margin17.5%$10.26B ÷ $58.74B
YoY Change+45.8%
5-Year CAGR+26.3%FY2020 → FY2025
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · AZN net income history · AZN profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2025$10.26B▲ +45.8%17.5%
FY2024$7.04B▲ +18.1%13.0%
FY2023$5.96B▲ +81.1%13.0%
FY2022$3.29B▲ +2835.7%7.4%
FY2021$112.0M▼ 96.5%0.3%

Net income vs peers (Healthcare)

#CompanyNet IncomeYoY
#1
AstraZeneca PLC
AstraZeneca PLCYOU
AZN
$10.26B+45.8%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$26.80B+90.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$20.64B+94.9%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$12.06B-16.3%
#5
AbbVie Inc.
AbbVie Inc.
ABBV
$4.23B-1.2%
Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

AstraZeneca PLC (AZN) reported net income of $10.26B for FY2025 (fiscal year ending 2025-12-31), up 45.8% year-over-year. The net profit margin was 17.5% — meaning the company kept $0.17 of every dollar of revenue as profit.

Based on available data, AstraZeneca PLC has been profitable since at least 2011. Net income reached a peak of $10.26B in FY2025. Data available for 15 fiscal years.

AstraZeneca PLC's net profit margin was 17.5% for FY2025, based on the latest annual results.

Investors sometimes search for "AstraZeneca PLC net worth" — the company's market capitalization is a separate figure from AZN net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Frequently asked questions

AZN net income · 5 questions

AstraZeneca PLC is profitable. The company reported net income of $10.26B for FY2025, a net profit margin of 17.5%. Net income was up 45.8% year-over-year. Based on available data, AstraZeneca PLC has been profitable since at least 2011.

is AZN profitabledoes AZN make a profitAZN profitabilityAZN profitable company

Source: FMP /income-statement · GAAP · AstraZeneca PLC · AstraZeneca PLC SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026